Search results
Jun 26, 2024 · Illumina is a global leader in genomic technologies that aims to improve human health by unlocking the power of the genome. Learn about its products, services, innovations, and impact in various fields and applications.
- Careers
At Illumina, we have the opportunity to do work that...
- Investors
At Illumina, our goal is to apply innovative technologies to...
- Management Team
Prior to Illumina, he was senior vice president of Agilent...
- About Us
In 2022, Illumina technology drove over 300,000 studies...
- Cellular & Molecular Biology
Illumina innovative sequencing and array technologies are...
- Sequencing Platforms
Innovative NGS platforms with proven performance and...
- Contact Us
At Illumina, our goal is to apply innovative technologies to...
- Explore All Products
Reach out for information about our products and services or...
- Careers
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Join Illumina, a global leader in genomic technology, and impact the future of human health. Explore opportunities in technology, science, engineering, sales, and more.
Illumina provides a range of products for genomic analysis, including sequencing kits, instruments, software, and IVD assays. Browse by product type, area of interest, instrument compatibility, or popular product lines.
Learn how Illumina next-generation sequencing (NGS) technology offers ultra-high throughput, scalability, and speed for various genomic studies. Explore the NGS workflow, methods, benefits, and applications, and access guides, tools, and articles.
Find support for Illumina instruments, library prep kits, microarrays, and software. Access webinars, online courses, training, and resources for Illumina products and services.
Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. "The addition of Fluent BioSciences to Illumina will provide significant and new capabilities to our customers in a key growth area and advances our multiomics ...